Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Is natural folate as effective as synthetic folic acid in increasing plasma and red blood cell folate concentrations during pregnancy? A proof-of-concept pilot study

FY 2018-19

Summary
Adequate folate status in early pregnancy is associated with prevention of neural tube defects (NTD). For this reason, Health Canada recommends pregnant women consume 0.4-1 mg/day of folic acid. Folic acid is a synthetic, man-made source of folate. A recently developed form of natural folate (Metafolin) is gaining popularity in Canada. It is being used increasingly in prenatal multivitamins, but has never been evaluated in pregnancy. Natural folate and folic acid are metabolized differently. Natural folate can enter circulation directly, whereas folic acid must be converted to folate through a series of steps. Recent evidence suggests that humans cannot convert such large doses of folic acid. In amounts as low as 0.2 mg/day, there is a build-up of unmetabolized folic acid in the blood, which has been associated with acceleration of some cancers and altered DNA development. Thus, natural folate may be safer for pregnant women and their babies than synthetic folic acid. We aim to test whether supplementation with natural folate can increase blood folate levels to at least 906nmol/L, a level associated with a very low risk of NTDs. Second, we aim to test if supplementation with natural folate results in lower unmetabolized folic acid levels, as compared to synthetic folic acid. We will randomize 60 healthy pregnant women to 0.6 mg folic acid or natural folate for 16 weeks. We will initiate the trial in later pregnancy, after neural tube closure, to reduce the risk of harm should the natural folate prove less effective. We will measure levels of serum folate, red blood cell folate, and unmetabolized folic acid. This proof-of-concept trial is the first step in determining the safest and most effective form of folate supplements for Canadian women and their babies.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406623
Name
Cochrane Kelsey
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Is natural folate as effective as synthetic folic acid in increasing plasma and red blood cell folate concentrations during pregnancy? A proof-of-concept pilot study
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Folate/Folic Acid; Neural Tube Defects; Nutrition; Pregnancy; Proof Of Concept Trial; Safety; Unmetabolized Folic Acid
Abstract
Adequate folate status in early pregnancy is associated with prevention of neural tube defects (NTD). For this reason, Health Canada recommends pregnant women consume 0.4-1 mg/day of folic acid. Folic acid is a synthetic, man-made source of folate. A recently developed form of natural folate (Metafolin) is gaining popularity in Canada. It is being used increasingly in prenatal multivitamins, but has never been evaluated in pregnancy. Natural folate and folic acid are metabolized differently. Natural folate can enter circulation directly, whereas folic acid must be converted to folate through a series of steps. Recent evidence suggests that humans cannot convert such large doses of folic acid. In amounts as low as 0.2 mg/day, there is a build-up of unmetabolized folic acid in the blood, which has been associated with acceleration of some cancers and altered DNA development. Thus, natural folate may be safer for pregnant women and their babies than synthetic folic acid. We aim to test whether supplementation with natural folate can increase blood folate levels to at least 906nmol/L, a level associated with a very low risk of NTDs. Second, we aim to test if supplementation with natural folate results in lower unmetabolized folic acid levels, as compared to synthetic folic acid. We will randomize 60 healthy pregnant women to 0.6 mg folic acid or natural folate for 16 weeks. We will initiate the trial in later pregnancy, after neural tube closure, to reduce the risk of harm should the natural folate prove less effective. We will measure levels of serum folate, red blood cell folate, and unmetabolized folic acid. This proof-of-concept trial is the first step in determining the safest and most effective form of folate supplements for Canadian women and their babies.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cochrane, Kelsey
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~